Understanding Midd Training Module 1
Let's dive into the details surrounding Midd Training Module 1. This lecture by Jeffrey Barrett from the Critical Path Institute describes the
Key Takeaways about Midd Training Module 1
- Stacy Tannenbaum, lead of the Pharmacometrics Group in the US for Astellas Pharma Global Development, reviews the various ...
- This lecture by Drs. Adekemi, Taylor, Rajesh Krishna and S.Y. Amy Cheung, Senior Directors of Integrated Drug Development at ...
- Stacy Tannenbaum, the lead of the Pharmacometrics Group in the US for Astellas Pharma Global Development, discusses ...
- Dr. Jeff Barrett from the Critical path Institute describes the application of
- Introduction to Pharmacovigilance under Good Pharmacovigilance Practice (GVP), covering the basics of drug safety and its ...
Detailed Analysis of Midd Training Module 1
Jeffrey Barrett from the Critical Path Institute provides the overview of this Rajesh Krishna, Senior Director with IDD Certara, reflects on how decision analysis can be used to support drug development. Dr. Qi Liu, the Assoc. Director for Innovation & Partnership in the Office of Clinical Pharmacology, Office of Translational Sciences ...
Do you have questions for the workshop speakers? Please email: MIDDWorkshop@fda.hhs.gov Detailed agenda: ...
That wraps up our extensive overview of Midd Training Module 1.